37 participants
Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-12-29
- Start Date:
- 2022-10-28
- Completion:
- 2024-02-01
Conditions
- Mucinous Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Cancer
Interventions
- DRUG
No Results Yet